arginine has been researched along with losartan potassium in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.65) | 18.7374 |
1990's | 13 (30.23) | 18.2507 |
2000's | 11 (25.58) | 29.6817 |
2010's | 17 (39.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kauma, H; Timonen, TT | 1 |
Asano, K; Kozutsumi, H; Satake, R; Takeuchi, M | 1 |
Landon, J; Ratcliffe, JG; Rees, LH; Scott, AP | 1 |
Contrera, JF; Smith, RJ | 1 |
Fisher, JW; Yoshioka, K | 1 |
Deng, X; Doll, AH; Snellen, H; Welch, WJ; Wilcox, CS | 1 |
Brookins, J; Fisher, JW; Ohigashi, T | 1 |
Bosch, J; Casadevall, M; Cirera, I; Elizalde, I; Goldin, E; Martínez-Cuesta, MA; Panés, J; Piqué, JM; Rodés, J; Terés, J | 1 |
Cameron, NE; Cotter, MA; Hohman, TC | 1 |
Chaisemartin, RA; Lartigue, M; Poux, JM | 1 |
Cass, RT; Giebel, LB; Matthews, DJ; Topping, RS | 1 |
Davis, KL; Grodberg, J; Sytkowski, AJ | 1 |
Bolton, LL; Cackovic, M; Chung, C; Kerstein, MD | 1 |
Ateshkadi, A; Vaziri, ND | 1 |
Noris, M; Remuzzi, G | 1 |
Acchiardo, SR; Cates, TB; Kang, ES; Miles, DE; Tevlin, MT | 1 |
Hasegawa, Y; Higuchi, M; Imagawa, S; Mukai, HY; Nagasawa, T; Neichi, T; Ozawa, K; Suzuki, N; Tarumoto, T; Yamamoto, M | 1 |
Imagawa, S; Mukai, HY; Nagasawa, T; Obara, N; Ohmine, K; Ozawa, K; Suzuki, N; Yamamoto, M | 1 |
Ang, S; Guan, Y; Jedlickova, K; Jelinek, J; Krishnamurti, L; Liu, E; Pastore, YD; Prchal, JT | 1 |
Bode-Böger, SM; Kielstein, JT; Martens-Lobenhoffer, J; Postel, SC; Scalera, F; Täger, M | 1 |
Cherian, L; Goodman, JC; Robertson, C | 2 |
Hirayama, A; Imagawa, S; Kobayashi, M; Nagasawa, T; Ozawa, K; Tarumoto, T | 1 |
Desai, A; Warren, JS; Zhao, Y | 1 |
Calò, LA; Davis, PA | 1 |
Appolonova, SA; Dikunets, MA; Rodchenkov, GM | 1 |
Surdacki, A; Wieczorek-Surdacka, E | 1 |
John, CC; Kutamba, E; Mugarura, K; Opoka, RO | 1 |
Choi, YB; Kang, CI; Kim, HH; Kim, NY; Shin, S; Yang, JM | 1 |
Higgins, SJ; Kain, KC; Liles, WC | 1 |
Fujiwara, N; Hikichi, Y; Kawagoe, Y; Nakamura, T; Node, K; Sato, E; Ueda, Y | 1 |
Bull, DA; Kim, SW; Kim, TI; Lee, M; Lee, Y; Nam, HY; Shin, SK | 1 |
Kim, J; Kim, SW; Lee, M; Lee, Y; Nam, HY; Shin, SK; Yockman, JW | 1 |
Righetti, M | 1 |
Bode-Böger, SM; Ehrenreich, H; Hecker, H; Joumaah, M; Kielstein, JT; Li, N; Lichtinghagen, R; Martens-Lobenhoffer, J; Weissenborn, K; Worthmann, H | 1 |
Kim, SW; Lee, M; Lee, Y; McGinn, AN; Nam, K; Olsen, CD; Shin, SK | 1 |
Balta, S; Korkmaz, H; Kurtoglu, E; Sincer, I | 1 |
Kielstein, JT; Weissenborn, K; Worthmann, H | 1 |
Kaye, DM; Nanayakkara, S; Rajapakse, NW | 1 |
Ando, A; Kawashima, M; Mikami, H; Naito, T; Nishimura, H; Nitta, K; Niwayama, J; Ogawa, T; Sanaka, T; Segawa, K; Soga, A; Teramoto, A; Yamatani, K; Yoshikura, T | 1 |
Liu, B; Niu, K; Shi, Y; Wang, L; Wang, T; Zhang, Y | 1 |
Abe, T; Ando, R; Fukami, K; Ito, S; Kaida, Y; Kimoto, M; Nakayama, Y; Saigusa, D; Sugiyama, M; Taguchi, K; Ueda, S; Yamagishi, SI; Yano, J; Yokoro, M | 1 |
de Oliveira-Fonoff, AM; Fernandes, F; Fonseca, KCB; Jordão, MR; Mady, C; Pessoa, FG; Ramires, FJA; Salemi, VMC | 1 |
7 review(s) available for arginine and losartan potassium
Article | Year |
---|---|
Tumour-associated hormonal products.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Arginine; Biliary Tract Diseases; Bronchial Neoplasms; Carcinoma; Chorionic Gonadotropin; Colonic Neoplasms; Cushing Syndrome; Erythropoietin; Female; Follicle Stimulating Hormone; Growth Hormone; Gynecomastia; Hormones, Ectopic; Humans; Hypercalcemia; Lactation Disorders; Lung Neoplasms; Luteinizing Hormone; Models, Biological; Neoplasms; Paraganglioma; Paraneoplastic Endocrine Syndromes; Polycythemia; Pregnancy; Prolactin; Thyroid Neoplasms; Vasopressins | 1974 |
Effects of epoetin on vascular biology.
Topics: Animals; Arginine; Blood Pressure; Endothelins; Erythropoietin; Hematocrit; Hemostasis; Humans; Nitric Oxide | 1999 |
Uremic bleeding: closing the circle after 30 years of controversies?
Topics: Anemia; Animals; Arginine; Bleeding Time; Blood Platelets; Endothelium, Vascular; Enzyme Inhibitors; Erythropoietin; Guanidines; Hemorrhage; History, 18th Century; History, 20th Century; Humans; Isoenzymes; Kidney Failure, Chronic; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Rats; Succinates; Uremia | 1999 |
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.
Topics: Antimalarials; Arginine; Erythropoietin; Humans; Levamisole; Malaria, Cerebral; Malaria, Falciparum; Plasmodium falciparum; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2010 |
Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
Topics: Africa; Antimalarials; Arginine; Clinical Trials as Topic; Dexamethasone; Epidemiologic Studies; Erythropoietin; Humans; Immunomodulation; Inflammation; Levamisole; Malaria, Cerebral; Malaria, Falciparum; Nitric Oxide; Plasmodium falciparum; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2011 |
Cardio-renal-anemia syndrome: a link between erythropoietin, dimethylarginine and homocysteine.
Topics: Anemia; Animals; Arginine; Cardio-Renal Syndrome; Erythropoietin; Homocysteine; Humans; Nitric Oxide Synthase; Vitamin B Complex | 2012 |
Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment.
Topics: Anti-Inflammatory Agents; Arginine; Biological Transport; Cardio-Renal Syndrome; Cardiovascular Agents; Cationic Amino Acid Transporter 1; Diuretics; Endothelium, Vascular; Erythropoietin; Heart; Hemodynamics; Humans; Inflammation Mediators; Kidney; Nitric Oxide; Oxidative Stress; Sympathetic Nervous System | 2015 |
3 trial(s) available for arginine and losartan potassium
Article | Year |
---|---|
L-arginine administration reverses anemia associated with renal disease.
Topics: Aged; Aged, 80 and over; Anemia; Arginine; Erythropoietin; Female; Hemoglobins; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Remission Induction; Reticulocyte Count | 2007 |
Renovascular protective effects of erythropoietin in patients with chronic kidney disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acute Kidney Injury; Aged; Arginine; Atherosclerosis; Biomarkers; Cardiovascular System; Carotid Intima-Media Thickness; Deoxyguanosine; Dose-Response Relationship, Drug; Erythropoietin; Fatty Acid-Binding Proteins; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Oxidative Stress; Prospective Studies; Recombinant Proteins; Treatment Outcome | 2011 |
Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Arginine; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Humans; Male; Middle Aged; Severity of Illness Index; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2013 |
33 other study(ies) available for arginine and losartan potassium
Article | Year |
---|---|
Therapeutic effect of heme arginate in myelodysplastic syndromes.
Topics: Adult; Aged; Alanine Transaminase; Arginine; Aspartate Aminotransferases; Bone Marrow; Creatinine; Erythropoietin; Female; Heme; Humans; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes | 1992 |
Chemical modification of erythropoietin: an increase in in vitro activity by guanidination.
Topics: Arginine; Biological Assay; Erythropoiesis; Erythropoietin; Guanidines; Humans; Lysine; Recombinant Proteins; Sialic Acids; Structure-Activity Relationship; Tyrosine | 1990 |
Cobalt-induced alterations in plasma proteins, proteases and kinin system of the rat.
Topics: Animals; Arginine; Blood Proteins; Bradykinin; Caseins; Cobalt; Erythropoietin; Esterases; Female; Hydrolysis; Kininogens; Kinins; Male; Peptide Hydrolases; Rats; Stimulation, Chemical; Time Factors; Uterus | 1974 |
Nitric oxide enhancement of erythropoietin production in the isolated perfused rat kidney.
Topics: Animals; Arginine; Base Sequence; DNA, Complementary; Erythropoietin; Hypoxia; In Vitro Techniques; Kidney; Male; Molecular Probes; Molecular Sequence Data; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Partial Pressure; Perfusion; Polymerase Chain Reaction; Rats; Rats, Wistar; RNA, Messenger | 1995 |
Nitric oxide mediates renal vasodilation during erythropoietin-induced polycythemia.
Topics: Animals; Arginine; Blood Pressure; Erythropoietin; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Polycythemia; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasodilation | 1993 |
Interaction of nitric oxide and cyclic guanosine 3',5'-monophosphate in erythropoietin production.
Topics: Animals; Arginine; Cyclic GMP; Erythropoietin; Female; Humans; In Vitro Techniques; Mice; Mice, Inbred C3H; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Polycythemia; Tumor Cells, Cultured | 1993 |
Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation.
Topics: Animals; Arginine; Blood Pressure; Enzyme Inhibitors; Erythropoietin; Gastric Mucosa; Hemoglobins; Hypertension, Portal; Male; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Splanchnic Circulation; Vascular Resistance; Vasodilation; Vasodilator Agents | 1996 |
Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.
Topics: Acetanilides; Aldehyde Reductase; Analysis of Variance; Animals; Arginine; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dietary Fats, Unsaturated; Enzyme Inhibitors; Erythropoietin; Fatty Acids, Essential; Flurbiprofen; Fructose; gamma-Linolenic Acid; Inositol; Linoleic Acids; Male; Neural Conduction; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oenothera biennis; Plant Oils; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Regression Analysis; Sciatic Nerve; Sorbitol; Sulfones | 1996 |
L-arginine has no effect on erythropoietin-induced hypertension in the excision remnant kidney model.
Topics: Administration, Oral; Animals; Arginine; Blood Pressure; Erythropoietin; Hypertension, Renal; Male; Nephrectomy; Rats; Rats, Wistar; Recombinant Proteins | 1996 |
A sequential dimerization mechanism for erythropoietin receptor activation.
Topics: Arginine; Base Sequence; Binding Sites; Binding, Competitive; Cell Division; Enzyme-Linked Immunosorbent Assay; Epitopes; Erythropoietin; Humans; In Vitro Techniques; Lysine; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Structure, Secondary; Receptors, Erythropoietin; Serine | 1996 |
Functional and structural role of arginine 103 in human erythropoietin.
Topics: Amino Acid Sequence; Animals; Arginine; Computer Simulation; COS Cells; Drug Stability; Erythropoietin; Genetic Variation; Humans; Mutagenesis, Site-Directed; Point Mutation; Recombinant Proteins; Thermodynamics | 1996 |
Leg ulceration in the sickle cell patient.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Bandages, Hydrocolloid; Butyrates; Colloids; Combined Modality Therapy; Cost-Benefit Analysis; Erythropoietin; Female; Hospital Costs; Humans; Leg Ulcer; Length of Stay; Male; Occlusive Dressings; Recombinant Proteins; Recurrence; Retrospective Studies; Wound Healing | 1998 |
Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease.
Topics: Anemia; Arginine; Erythropoietin; Hematocrit; Hemoglobins; Humans; Hypotension; Kidney Failure, Chronic; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Renal Dialysis; Skin Temperature | 2001 |
L-arginine rescues decreased erythropoietin gene expression by stimulating GATA-2 with L-NMMA.
Topics: Anemia; Animals; Arginine; Cell Hypoxia; Cells, Cultured; Cyclic GMP; DNA-Binding Proteins; Enzyme Inhibitors; Erythropoietin; GATA2 Transcription Factor; Gene Expression; Humans; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Oxygen; Promoter Regions, Genetic; RNA, Messenger; Transcription Factors; Uremia | 2002 |
GATA suppresses erythropoietin gene expression through GATA site in mouse erythropoietin gene promoter.
Topics: Animals; Arginine; Binding Sites; Catalase; DNA-Binding Proteins; Down-Regulation; Erythroid-Specific DNA-Binding Factors; Erythropoietin; GATA2 Transcription Factor; GATA3 Transcription Factor; Hydrogen Peroxide; Mice; omega-N-Methylarginine; Promoter Regions, Genetic; Trans-Activators; Transcription Factors; Transfection; Tumor Cells, Cultured | 2002 |
Mutations in the VHL gene in sporadic apparently congenital polycythemia.
Topics: Adolescent; Adult; Arginine; Aspartic Acid; Base Sequence; Child; Child, Preschool; DNA Mutational Analysis; Erythroid Precursor Cells; Erythropoietin; Female; Heterozygote; Homozygote; Humans; Leucine; Ligases; Male; Mutation; Pedigree; Polycythemia; Sequence Analysis, DNA; Tryptophan; Tumor Suppressor Proteins; Tyrosine; Ubiquitin-Protein Ligases; Valine; Von Hippel-Lindau Tumor Suppressor Protein | 2003 |
Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase.
Topics: Amidohydrolases; Antioxidants; Arginine; Cells, Cultured; Darbepoetin alfa; Endothelial Cells; Erythropoietin; Humans; Intracellular Membranes; Nitric Oxide; Oxidative Stress; Pyrrolidines; Recombinant Proteins; Thiocarbamates | 2005 |
Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats.
Topics: Animals; Arginine; Brain Injuries; Cell Count; Cerebral Cortex; Cerebrovascular Circulation; Erythropoietin; Hippocampus; Humans; Laser-Doppler Flowmetry; Neurons; Neuroprotective Agents; Nitric Oxide; Rats; Rats, Long-Evans; Recombinant Proteins | 2007 |
Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Topics: Amidohydrolases; Animals; Arginine; Base Sequence; Cells, Cultured; DNA Primers; Endothelial Cells; Epoetin Alfa; Erythropoietin; Humans; Kidney; Kidney Failure, Chronic; Liver; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Recombinant Proteins; Up-Regulation; Vascular Diseases | 2008 |
EPO induces rise in serum ADMA but does not prevent the increase in NO release: the likely involvement of HO-1.
Topics: Animals; Apoptosis; Arginine; Endothelium, Vascular; Epoetin Alfa; Erythropoietin; Heme Oxygenase-1; Humans; Kidney Failure, Chronic; Nitric Oxide; Nitric Oxide Synthase; Recombinant Proteins; Renal Dialysis | 2008 |
Possible indirect detection of rHuEPO administration in human urine by high-performance liquid chromatography tandem mass spectrometry.
Topics: Adult; Amidohydrolases; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Citrulline; Doping in Sports; Erythropoietin; Humans; Injections, Intravenous; Male; Nitric Oxide Synthase; Predictive Value of Tests; Recombinant Proteins; Reference Values; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tandem Mass Spectrometry | 2008 |
Endothelial and red blood cell turnover rate--factors possibly affecting circulating ADMA levels?
Topics: Amidohydrolases; Arginine; Endothelial Cells; Erythrocytes; Erythropoietin; Humans | 2009 |
An hydrophobically modified arginine peptide vector system effectively delivers DNA into human mesenchymal stem cells and maintains transgene expression with differentiation.
Topics: Adipocytes; Arginine; Cell Differentiation; Cell Survival; Cells, Cultured; DNA; Drug Delivery Systems; Erythropoietin; Flow Cytometry; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; Humans; Mesenchymal Stem Cells; Microscopy, Atomic Force; Osteoblasts; Peptide Fragments; Transfection; Transgenes | 2010 |
Improved cerebrovascular function and reduced histological damage with darbepoietin alfa administration after cortical impact injury in rats.
Topics: Anatomy, Cross-Sectional; Animals; Arginine; Brain Injuries; Cerebral Cortex; Cerebrovascular Circulation; Darbepoetin alfa; Dose-Response Relationship, Drug; Erythropoietin; Hematinics; Laser-Doppler Flowmetry; Neuroprotective Agents; Nitric Oxide; Rats; Rats, Long-Evans; Rats, Sprague-Dawley | 2011 |
Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system.
Topics: Animals; Apoptosis; Arginine; Cell Line; Cell Survival; DNA; Drug Carriers; Erythrocytes; Erythropoietin; Hemolysis; Leukocytes, Mononuclear; Nanoparticles; Polymers; Rats; Rats, Sprague-Dawley; Transfection | 2012 |
Human erythropoietin gene delivery using an arginine-grafted bioreducible polymer system.
Topics: Anemia; Animals; Arginine; DNA; Erythrocytes; Erythropoiesis; Erythropoietin; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Hematocrit; Humans; Kidney; Male; Nanoparticles; Polyamines; Random Allocation; Rats; Reticulocytosis; RNA, Messenger; Transfection | 2012 |
Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats.
Topics: Animals; Arginine; Cardiotonic Agents; Erythropoietin; Gene Transfer Techniques; Male; Myocardial Infarction; Myocardium; Polyamines; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2013 |
Letter by Kurtoglu et al regarding article, "Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke".
Topics: Arginine; Drug Therapy, Combination; Erythropoietin; Female; Humans; Male; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator | 2013 |
Response to letter regarding article, "Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke".
Topics: Arginine; Drug Therapy, Combination; Erythropoietin; Female; Humans; Male; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator | 2013 |
Modulation of circulating endothelial progenitor cells by erythropoiesis-stimulating agents in patients with chronic kidney disease stage G5 and 5D
.
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Cell Count; Darbepoetin alfa; Endothelial Progenitor Cells; Erythropoietin; Female; Hematinics; Humans; Kidney Failure, Chronic; Male; Matrix Metalloproteinase 2; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis; Vascular Endothelial Growth Factor A | 2016 |
Association of the -449GC and -1151AC polymorphisms in the DDAH2 gene with asymmetric dimethylarginine and erythropoietin resistance in Chinese patients on maintenance hemodialysis.
Topics: Alleles; Amidohydrolases; Arginine; Asian People; Erythropoietin; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Renal Dialysis | 2017 |
Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia.
Topics: Aged; Amidohydrolases; Anemia; Animals; Arginine; Cytokines; Drug Resistance; Erythrocyte Indices; Erythrocytes; Erythropoietin; Female; Gene Expression; Hematinics; Hematocrit; Hemoglobins; Humans; Male; Mice; Middle Aged; Muscle Proteins; Nephrectomy; Plasma; Receptors, Erythropoietin; Renal Insufficiency, Chronic | 2017 |
Erythropoietin reduces collagen deposition after myocardial infarction but does not improve cardiac function.
Topics: Animals; Apoptosis; Arginine; Collagen; Diastole; Erythropoietin; Glutathione; Heart; Hematocrit; Hemoglobins; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Rats | 2018 |